Not Yet RecruitingNCT07585383
Official study titleA Randomized, Double-blind, Placebo-controlled, Dose-escalating Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of Single and Multiple Doses of KR23248 Capsules in Healthy Adult Subjects
This study isn't recruiting yet.
Location not clearly listedSchizophreniaMedication studyAges 18–45
- Countries
- Sponsor
- Jiangxi Kvvit Pharmaceutical Co., Ltd.
Not Yet RecruitingNCT05823805
Official study titleApproaches For ThE pRioritization of Patients in priMAry Care Post-COVID To Reduce Health Inequities (AFTERMATH): Cluster Randomized Controlled Trial
This study isn't recruiting yet.
Location not clearly listedSchizophrenia, BipolarityInterventional studyAges 18+
- Countries
- Sponsor
- Unity Health Toronto
Not Yet RecruitingNCT07585656
Official study titleComparison of the Italian and US Forensic Models Regarding Dual Diagnosis Offenders: a 3-year Longitudinal Study
This study isn't recruiting yet.
Location not clearly listedSchizophreniaObservational studyAges 18–75
- Countries
- Sponsor
- University of Bari
Not Yet RecruitingNCT06695676
Official study titleEvaluation of Left Ventricle Systolic Functions of Patients On Lurasidone
This study isn't recruiting yet.
In AydinSchizophrenia, BipolarityObservational studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Aydin Adnan Menderes University
Not Yet RecruitingNCT05946486
Official study titlePhase III Randomized, Multicenter Open Label Study to Evaluate the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity.
This study isn't recruiting yet.
Multiple locations, including BordeauxSchizophreniaMedication studyAges 6+
- Countries
- France
- Sponsor
- University Hospital, Bordeaux
Not Yet RecruitingNCT07555275
Official study titleA Multisited Efficacy Trial of Veteran Voices and Visions
This study isn't recruiting yet.
Multiple locations, including West Los AngelesSchizophreniaBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)
Enrolling By InvitationNCT05703412
Official study titleEffectiveness of a Multi-component mHealth Intervention to Improve Post-hospital Transitions of Care for Patients With SMI
This study is by invitation only.
In ProvidenceSchizophrenia, Bipolarity, ...Behavioural studyAges 18+
- Countries
- United States
- Sponsor
- Butler Hospital
CompletedNCT00095524
Official study titleA Multicenter, Randomized, Double-Blind Study on the Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–65
- Countries
- United States, United Kingdom, Brazil
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)